References
Abidi, S. M. A.; Howard, E. H.; Pento, J. T. Differential influence of antiestrogens on the in vitro release of gelatinases by invasive and non-invasive breast cancer cells. Clin. Exp. Metastasis 15:432–439; 1997.
Arteaga, C. L.; Hurd, S. D.; Winnier, A. R., et al. TGF-β antibodies inhibit breast cancer cell tumorigenicity. Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J. Clin. Invest. 92:2569–2576; 1993.
Chen, J. C.; Shao, Z. M.; Sheikh, M. S., et al. IGF-binding protein-3 enhancement of DNA synthesis in breast carcinoma cells. Am. Assoc. Cancer Res. 34:238; 1993.
Cullen, K. J.; Allison, A.; Martine, I., et al. IGF expression in breast cancer epithelium and stroma. Breast Cancer Res. Treat. 22:21–29; 1992.
Gherardi, E. Growth factors and cell movement. Eur. J. Cancer 27:403–405; 1991.
Klijin, J. G. M.; Berns, P. M. J.; Schmitz, P. I. M., et al. The clinical significance of EGF receptor in human breast cancer: a review of 5232 patients. Endocr. Rev. 13:3–17; 1992.
Lyons, R. M.; Moses, H. L. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:467–473; 1990.
Matthay, M. A.; Thiery, J. P.; Lafont, F., et al. Transient effect of EGF on the motility of an immortalized mammary epithelial cell line. J. Cell Sci. 106:869–878; 1993.
Rajah, T. T.; Pento, J. T. Influence of antiestrogens on the invasiveness and laminin attachment of MDA-MB-231 breast cancer cells. Cancer Invest. 17:10–18; 1999.
Theriot, J. A.; Mitchison, T. J. Actin microfilament dynamics in locomoting cells. Nature 352:126–131; 1991.
Tong, G. M.; Rajah, T. T.; Pento, J. T. Influence of antiestrogens on EGF-and IGF-I-mediated proliferation of human breast cancer cells. In Vitro Cell. Dev. Biol. 35:19–21; 1999.
Welch, D. R.; Fabra, A.; Nakajima, M. TGF-β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA 87:7678–7682; 1990.
Zugmaier, G.; Ennis, B. W.; Deschauer, B., et al. Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines. J. Cell. Physiol. 141:353–361; 1989.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tong, G.M., Rajah, T.T. & Pento, J.T. The differential influence of EGF, IGF-I, and TGF-β on the invasiveness of human breast cancer cells. In Vitro Cell.Dev.Biol.-Animal 36, 493–494 (2000). https://doi.org/10.1290/1071-2690(2000)036<0493:TDIOEI>2.0.CO;2
Received:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2000)036<0493:TDIOEI>2.0.CO;2